Journal of Capital Medical University ›› 2008, Vol. 29 ›› Issue (1): 96-99.

• 综述 • Previous Articles     Next Articles

The Progressive Study of HER2 Gene and Target Therapy in Breast Cancer

Qiao Shanshan1, Wang Daye2   

  1. 1. Beijing Friendship Hospital, Capital Medical University;2. Clinical Pathology Center, Capital Medical University
  • Received:2006-09-19 Revised:1900-01-01 Online:2008-02-24 Published:2013-07-15

Abstract: HER2 and Herceptin(anti-HER2 monoclonal antibody) are on focus of breast cancer studying recently.Many reports summaries the clinical efficacy and safety findings from clinical trials of the new anti-HER2 monoclonal antibody Herceptin,it is active when added to chemotherapy in patients with advanced metastatic breast cancer.

Key words: breast cancer, HER2, therapeutic target, Herceptin

CLC Number: